Preda, C M <br/><br/>
Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.  [electronic resource] 

 -  Journal of viral hepatitis  07 2018 
 - 834-841 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2893 
<br/><br/><label>Standard No.: </label>10.1111/jvh.12872  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alanine Transaminase--blood<br/>Antiviral Agents--therapeutic use<br/>Drug Therapy, Combination--methods<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B virus--classification<br/>Hepatitis B, Chronic--complications<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Incidence<br/>Liver Cirrhosis--virology<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Risk Assessment<br/>Romania--epidemiology<br/>Viral Load<br/>Virus Activation